EAM: 2-[(4S)-6-(4-chlorophenyl)-8-methoxy-1-methyl-4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepin-4-yl]-N-ethylacetamide
EAM is a Ligand Of Interest in 3P5O designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3P5O_EAM_A_1 | 93% | 53% | 0.062 | 0.963 | 0.48 | 1.17 | - | 5 | 1 | 0 | 100% | 1 |
| 2YEK_EAM_B_1183 | 95% | 61% | 0.058 | 0.968 | 0.45 | 0.88 | - | 1 | 0 | 0 | 100% | 1 |
| 24OS_EAM_A_500 | 80% | 10% | 0.072 | 0.923 | 1.75 | 2.44 | 7 | 16 | 0 | 0 | 100% | 1 |
| 5DFC_EAM_A_503 | 67% | 13% | 0.101 | 0.909 | 2.18 | 1.73 | 10 | 6 | 0 | 0 | 100% | 1 |
